MiMedx Group, Inc. Business Acquisition, Pro Forma Revenue
MiMedx Group, Inc. (MDXG) reported Business Acquisition, Pro Forma Revenue of $233.99 million for the 12-month period ending 2016-12-31, per its 10-K filed 2020-03-17.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2020-03-17
- MiMedx Group, Inc. business acquisition, pro forma revenue for the quarter ending 2016-12-31 was $58.30M, a 4.18% increase year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma revenue for the quarter ending 2016-09-30 was $64.43M, a 23.65% increase year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma revenue for the quarter ending 2016-06-30 was $57.34M, a 13.57% increase year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma revenue for the quarter ending 2016-03-31 was $53.91M, a 17.41% increase year-over-year.
- MiMedx Group, Inc. business acquisition, pro forma revenue for fiscal 2016 was $233.99M, a 14.43% increase from fiscal 2015.
- MiMedx Group, Inc. business acquisition, pro forma revenue for fiscal 2015 was $204.48M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $58.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $122.73M derived: sum of 2 quarters · filed 2020-03-17 | $180.07M derived: sum of 3 quarters · filed 2020-03-17 | $233.99M 10-K · filed 2020-03-17 | $245.56M 10-K · filed 2017-03-01 |
| 2016-09-30 | $64.43M 10-Q · filed 2016-11-08 | $121.77M derived: sum of 2 quarters · filed 2016-11-08 | $175.69M 10-Q · filed 2016-11-08 | $231.65M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2016-06-30 | $57.34M 10-Q · filed 2016-08-02 | $111.26M 10-Q · filed 2016-08-02 | $167.22M derived: sum of 3 quarters · filed 2017-03-01 | $219.32M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2016-03-31 | $53.91M 10-Q · filed 2016-05-10 | $109.88M derived: sum of 2 quarters · filed 2017-03-01 | $161.98M derived: sum of 3 quarters · filed 2017-03-01 | $212.47M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-12-31 | $55.96M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $108.07M derived: sum of 2 quarters · filed 2017-03-01 | $158.56M derived: sum of 3 quarters · filed 2017-03-01 | $204.48M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $52.11M 10-Q · filed 2016-11-08 | $102.60M derived: sum of 2 quarters · filed 2016-11-08 | $148.52M 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | $50.49M 10-Q · filed 2016-08-02 | $96.41M 10-Q · filed 2016-08-02 | |||
| 2015-03-31 | $45.92M 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |